Drug Release Profile

A drug release profile describes how the amount or concentration of an active pharmaceutical ingredient becomes available from a dosage form over time, helping predict therapeutic performance. Release occurs through processes such as dissolution, diffusion, erosion, or degradation, and depends on formulation properties, drug solubility, matrix structure, and surrounding conditions. In clinical research, scientists measure release under controlled laboratory conditions and analyze the resulting time-dependent curve to compare formulations and assess consistency. These profiles support the development of immediate-, extended-, and controlled-release medicines, informing dosing schedules, treatment duration, efficacy, and potential safety considerations.

Drug Release Profile - Related Videos

Education

JoVE Core - Pharmacokinetics and Pharmacodynamics

Modified-Release Drug Delivery Systems: Drug Release Characteristics

0 Views •

2026

Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...

Drugs Affecting Neurotransmitter Release or Uptake

0 Views •

2023

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...

Research

JoVE EoE - Assay Techniques

A Plate-Based Assay to Measure Monoamine Release from Brain Slices on Test Drug Exposure

0 Views •

2025

In this video, we demonstrate an assay that investigates monoamine release mechanisms from the neurons of metabolically active ex vivo rat brain slices, when treated with test drugs. The assay demonstrates that neurostimulant drugs induce monoamine release via the cellular monoamine transporters, whereas high KCl concentration induces synaptic vesicle exocytosis-mediated vesicular monoamine release.

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

0 Views •

Cited by 10 •

2016

We present a facile method to fabricate a biodegradable gelatin-based drug release platform that is magneto-thermally responsive. This was achieved by incorporating superparamagnetic iron oxide nanoparticles and poly(N-isopropylacrylamide-co-acrylamide) within a spherical gelatin micro-network crosslinked by genipin, in conjunction with an alternating magnetic field application system.

Modified-Release Drug Delivery Systems: Overview

0 Views •

2026

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...

View All Results

FAQs

Related Topics